Argenx
ARGX
#638
Rank
NZ$51.51 B
Marketcap
$861.53
Share price
-0.62%
Change (1 day)
-0.57%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: NZ$51.51 Billion

As of September 2024 Argenx has a market cap of NZ$51.51 Billion. This makes Argenx the world's 638th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$51.51 B44.37%
2023NZ$35.68 B8.1%
2022NZ$33.01 B22.93%
2021NZ$26.85 B37.73%
2020NZ$19.49 B91.2%
2019NZ$10.19 B95.17%
2018NZ$5.22 B85.07%
2017NZ$2.82 B
2014NZ$0.18 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Argenx was reported to be:

NZ$51.51 Billion
by Yahoo Finance info icon info icon
NZ$51.51 Billion
by CompaniesMarketCap info icon info icon
NZ$50.99 Billion
by Nasdaq info icon info icon